Talk:Dasotraline
Appearance
This is the talk page for discussing improvements to the Dasotraline article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
![]() | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
|
![]() | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Dasotraline.
|
Either name or structure is wrong
[edit]Looking at the recently approved USANs I found an entry for Dastroline (http://www.ama-assn.org/resources/doc/usan/x-pub/dasotraline.pdf) which contains the identifier SEP-225289 and has a very different structure - this has been registered on behalf of Sunovion - which is the new name of Sepracor. I have tried to look at all of the listed references in this article to see where the name/structure relationship may come from I don't have access to all of them and none of hte ones that I do have access to showed the structure. --The chemistds (talk) 16:17, 16 September 2014 (UTC)